Breakthrough Discovery in Cellular Energy Balance: Potential New Therapies for Parkinson's and Rare Disorders

Strategic Insights -

Experts from Universita Cattolica, Rome campus, and Roma Tre University have made a significant discovery in the realm of cellular energy balance, identifying a key switch called phosphatase B55 (PP2A-B55alpha) that regulates the balance of mitochondria. This breakthrough could lead to new therapies for diseases ranging from Parkinson's to rare disorders caused by defects in the mitochondria. The study, led by Francesco Cecconi and Valentina Cianfanelli, found that reducing the activity of B55 could attenuate the motor symptoms of Parkinson's in a preclinical model of the disease.

Key Takeaways:

  • The discovery of phosphatase B55 (PP2A-B55alpha) as a key switch for cellular energy balance has significant implications for the development of new therapies for diseases caused by mitochondrial defects.
  • The study found that reducing B55 activity can attenuate the motor symptoms of Parkinson's disease in a preclinical model.
  • B55 plays a crucial role in regulating mitochondrial homeostasis, promoting the removal of damaged mitochondria and preventing excessive production of new organelles.
  • The functional interaction between B55 and Parkin, a central protein in mitophagy mechanisms, is critical for the effects of B55 on mitochondrial biogenesis.
  • The discovery has potential applications in the development of small molecules that can selectively act on dopaminergic neurons and mitigate their death.
  • A 'universal' drug that regulates the action of B55 could be developed for various mitochondrial diseases, including some mitochondrial myopathies and neurodegenerative diseases.
  • The deregulation of mitochondrial quality and number also underlies the plasticity of tumor cells and their ability to resist therapies, making controlling B55 a promising approach in oncology.

Statistics:

  • The study was led by Francesco Cecconi, Full Professor of Biochemistry at the Universita Cattolica, and Valentina Cianfanelli, Associate Professor at the Department of Science at Roma Tre University.
  • The study was published in Science Advances.
  • Mitochondria are responsible for producing the energy cells need to survive.
  • Parkinson's disease is associated with the loss of mitochondria and the death of dopaminergic neurons.
  • The study used animal models of Parkinson's disease (Drosophila, the fruit flies) to test the effects of reducing B55 levels.
  • The results showed that by reducing B55 levels, it is possible to improve both the motor defects and the mitochondrial alterations typical of the disease.

Sources:

  • Science Advances, "Aph-1r regulates mitochondrial biogenesis and mitophagy in Drosophila" by Valentina Cianfanelli, et al.
  • Universita Cattolica, Rome campus, and Roma Tre University.
  • NewsRx LLC, "Breakthrough Discovery in Cellular Energy Balance: Potential New Therapies for Parkinson's and Rare Disorders" (2025).